Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

Overview of attention for article published in Journal for Immunotherapy of Cancer, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users

patent: 2 patents

Readers on

mendeley: 80 Mendeley

Summary X Patents

So far, Altmetric has seen 2 patents that reference this research output.

Enhancing the therapeutic activity of immune checkpoint inhibitor

Grant US-10906977-B2

United States of America

Enhancing the therapeutic activity of an immune checkpoint inhibitor

Grant US-10881732-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.